Keyphrases
Umbilical Cord Blood Transplantation
100%
Transplant Outcomes
100%
Umbilical Cord Blood
100%
Myeloablative Conditioning
100%
Hematological Diseases
100%
Graft-versus-host Disease (GvHD)
40%
Clinical Features
40%
Event-free Survival
40%
Cord Blood Unit
40%
Favorable Risk
40%
Risk Factors
20%
Nonmyeloablative
20%
Cyclosporine
20%
Mycophenolate Mofetil
20%
High Risk
20%
Transplantation Therapy
20%
Older Patients
20%
Cyclophosphamide
20%
Fludarabine
20%
Total Body Irradiation
20%
Fungal Infection
20%
Human Leukocyte Antigen
20%
Pretransplant
20%
Nucleated Cells
20%
Neutrophil Recovery
20%
Transplant-related Mortality
20%
Karnofsky Performance Status
20%
Cell Dose
20%
Immunoprophylaxis
20%
Organ Dysfunction
20%
Single Fraction
20%
Risk Factors for Survival
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hematologic Disease
100%
Event Free Survival
100%
Clinical Feature
100%
Graft Versus Host Reaction
50%
Ciclosporin
50%
Mycophenolate Mofetil
50%
Chronic Graft Versus Host Disease
50%
Cyclophosphamide
50%
Leukocyte Antigen
50%
Mycosis
50%
Fludarabine
50%
Medicine and Dentistry
Cord Blood
100%
Sulfhemoglobinemia
100%
Cord Blood Stem Cell Transplantation
100%
Nonmyeloablative Conditioning
100%
Clinical Feature
33%
Event Free Survival
33%
Mycosis
16%
Neutrophil
16%
Whole Body Radiation
16%
Fludarabine
16%
Cyclophosphamide
16%
Cyclosporine
16%
Chronic Graft Versus Host Disease
16%
Mycophenolate Mofetil
16%
Target Cell
16%
Human Leukocyte Antigen
16%
Immunoprophylaxis
16%
Graft Versus Host Reaction
16%
Immunology and Microbiology
Umbilical Cord Blood
100%
Cord Blood Stem Cell Transplantation
100%
Conditioning
100%
Event Free Survival
33%
Graft-Versus-Host Disease
16%
Ciclosporin
16%
Chronic Graft Versus Host Disease
16%
Target Cell
16%
Human Leukocyte Antigen
16%
Cyclophosphamide
16%
Neutrophil
16%
Mycophenolate Mofetil
16%